A citation-based method for searching scientific literature

David Stanek, Dana M Bis-Brewer, Cima Saghira, Matt C Danzi, Pavel Seeman, Petra Lassuthova, Stephan Zuchner. Database (Oxford) 2020
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
33

RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.
April E Deveaux, Tyler A Allen, Muthana Al Abo, Xiaodi Qin, Dadong Zhang, Brendon M Patierno, Lin Gu, Jhanelle E Gray, Chad V Pecot, Holly K Dressman,[...]. Lung Cancer 2021
2
50

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
33

The role of alternative splicing in cancer drug resistance.
Zahava Siegfried, Rotem Karni. Curr Opin Genet Dev 2018
63
33


Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Kuniaki Sato, Takaaki Masuda, Qingjiang Hu, Taro Tobo, Shinya Kidogami, Yushi Ogawa, Tomoko Saito, Sho Nambara, Hisateru Komatsu, Hidenari Hirata,[...]. Anticancer Res 2017
18
33

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.
Steffen Durinck, Paul T Spellman, Ewan Birney, Wolfgang Huber. Nat Protoc 2009
33

Widespread intron retention diversifies most cancer transcriptomes.
Heidi Dvinge, Robert K Bradley. Genome Med 2015
162
33

MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
Xin Zhang, Ramona Schulz, Shelley Edmunds, Elke Krüger, Elke Markert, Jochen Gaedcke, Estelle Cormet-Boyaka, Michael Ghadimi, Tim Beissbarth, Arnold J Levine,[...]. Mol Cell 2015
51
33

Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
Reyka G Jayasinghe, Song Cao, Qingsong Gao, Michael C Wendl, Nam Sy Vo, Sheila M Reynolds, Yanyan Zhao, Héctor Climente-González, Shengjie Chai, Fang Wang,[...]. Cell Rep 2018
100
33

Splice-switching antisense oligonucleotides as therapeutic drugs.
Mallory A Havens, Michelle L Hastings. Nucleic Acids Res 2016
200
33

Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity.
Aleix Prat, Barbara Adamo, Cheng Fan, Vicente Peg, Maria Vidal, Patricia Galván, Ana Vivancos, Paolo Nuciforo, Héctor G Palmer, Shaheenah Dawood,[...]. Sci Rep 2013
39
33

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
Howard I Scher, Susan Halabi, Ian Tannock, Michael Morris, Cora N Sternberg, Michael A Carducci, Mario A Eisenberger, Celestia Higano, Glenn J Bubley, Robert Dreicer,[...]. J Clin Oncol 2008
33

Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Yanru Wang, Jennifer A Freedman, Hongliang Liu, Patricia G Moorman, Terry Hyslop, Daniel J George, Norman H Lee, Steven R Patierno, Qingyi Wei. Int J Cancer 2017
14
33

Aberrant RNA Splicing in Cancer and Drug Resistance.
Bi-Dar Wang, Norman H Lee. Cancers (Basel) 2018
78
33

Splicing Factor Mutations in Cancer.
Rafael Bejar. Adv Exp Med Biol 2016
29
33

Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs.
Yongchu Pan, Hongliang Liu, Yanru Wang, Xiaozheng Kang, Zhensheng Liu, Kouros Owzar, Younghun Han, Li Su, Yongyue Wei, Rayjean J Hung,[...]. Sci Rep 2017
5
33

The Molecular Signatures Database (MSigDB) hallmark gene set collection.
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir, Mahmoud Ghandi, Jill P Mesirov, Pablo Tamayo. Cell Syst 2015
33

How We Think about Targeting RNA with Small Molecules.
Matthew G Costales, Jessica L Childs-Disney, Hafeez S Haniff, Matthew D Disney. J Med Chem 2020
40
33

PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways.
Li Liao, Mengxi Ge, Qiong Zhan, Ruofan Huang, Xiaoyu Ji, Xiaohua Liang, Xinli Zhou. Int J Biol Sci 2019
5
33

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
A Sveen, S Kilpinen, A Ruusulehto, R A Lothe, R I Skotheim. Oncogene 2016
264
33

Proteasome inhibitors in cancer therapy.
Elisabet E Manasanch, Robert Z Orlowski. Nat Rev Clin Oncol 2017
341
33

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
33

TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.
Michael Ryan, Wing Chung Wong, Robert Brown, Rehan Akbani, Xiaoping Su, Bradley Broom, James Melott, John Weinstein. Nucleic Acids Res 2016
162
33


Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
André Kahles, Kjong-Van Lehmann, Nora C Toussaint, Matthias Hüser, Stefan G Stark, Timo Sachsenberg, Oliver Stegle, Oliver Kohlbacher, Chris Sander, Gunnar Rätsch. Cancer Cell 2018
262
33

Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
Antje Arnold, Ming Yuan, Antionette Price, Lauren Harris, Charles G Eberhart, Eric H Raabe. Neuro Oncol 2020
13
33



Intron retention is a widespread mechanism of tumor-suppressor inactivation.
Hyunchul Jung, Donghoon Lee, Jongkeun Lee, Donghyun Park, Yeon Jeong Kim, Woong-Yang Park, Dongwan Hong, Peter J Park, Eunjung Lee. Nat Genet 2015
185
33

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models.
Yesim Gökmen-Polar, Yi Liu, Rachel A Toroni, Kerry L Sanders, Rutika Mehta, Sunil Badve, Christian Rommel, George W Sledge. Breast Cancer Res Treat 2012
54
33


Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
Hansong Wang, Stephanie L Schmit, Christopher A Haiman, Temitope O Keku, Ikuko Kato, Julie R Palmer, David van den Berg, Lynne R Wilkens, Terrilea Burnett, David V Conti,[...]. Int J Cancer 2017
16
33




Explaining the race difference in prostate cancer stage at diagnosis.
Beth A Jones, Wen-Liang Liu, Andre B Araujo, Stanislav V Kasl, Stephanie N Silvera, Hosanna Soler-Vilá, Mary G M Curnen, Robert Dubrow. Cancer Epidemiol Biomarkers Prev 2008
68
33

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
33

The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer.
Ettaib El Marabti, Ihab Younis. Front Mol Biosci 2018
104
33

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
33

Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.
Sunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, Michael Seiler, Doug Robinson, Jinesh Gheeya, Ming Yao, Grethe I Grenaker Alnæs, Deborah Toppmeyer, Margit Riis,[...]. Sci Rep 2017
20
33

Alternative isoform regulation in human tissue transcriptomes.
Eric T Wang, Rickard Sandberg, Shujun Luo, Irina Khrebtukova, Lu Zhang, Christine Mayr, Stephen F Kingsmore, Gary P Schroth, Christopher B Burge. Nature 2008
33

Splicing-factor alterations in cancers.
Olga Anczuków, Adrian R Krainer. RNA 2016
113
33

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.
Dingxiao Zhang, Qiang Hu, Xiaozhuo Liu, Yibing Ji, Hsueh-Ping Chao, Yan Liu, Amanda Tracz, Jason Kirk, Silvia Buonamici, Ping Zhu,[...]. Nat Commun 2020
25
33

Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Michael Seiler, Shouyong Peng, Anant A Agrawal, James Palacino, Teng Teng, Ping Zhu, Peter G Smith, Silvia Buonamici, Lihua Yu. Cell Rep 2018
154
33

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
A Gordon Robertson, Juliann Shih, Christina Yau, Ewan A Gibb, Junna Oba, Karen L Mungall, Julian M Hess, Vladislav Uzunangelov, Vonn Walter, Ludmila Danilova,[...]. Cancer Cell 2017
334
33



Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.
Bi-Dar Wang, Kristin Ceniccola, SuJin Hwang, Ramez Andrawis, Anelia Horvath, Jennifer A Freedman, Jacqueline Olender, Stefan Knapp, Travers Ching, Lana Garmire,[...]. Nat Commun 2017
52
33

Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.
Jennifer A Freedman, Yanru Wang, Xuechan Li, Hongliang Liu, Patricia G Moorman, Daniel J George, Norman H Lee, Terry Hyslop, Qingyi Wei, Steven R Patierno. Carcinogenesis 2018
5
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.